Both diffusion-limited and perfusion-limited
hypoxia are associated with
tumor progression,
metastasis, and the resistance to therapeutic modalities. A strategy that can efficiently overcome both types of
hypoxia to enhance the efficacy of
cancer treatment has not been reported yet. Here, it is shown that by using biomimetic ultrathin
graphdiyne oxide (GDYO) nanosheets, both types of
hypoxia can be simultaneously addressed toward an ideal
photodynamic therapy (
PDT). The GDYO nanosheets, which are oxidized and exfoliated from
graphdiyne (GDY), are able to efficiently catalyze water oxidation to release O2 and generate
singlet oxygen (1O2) using near-infrared irradiation. Meanwhile, GDYO nanosheets also exhibit excellent light-to-heat conversion performance with a photothermal conversion efficiency of 60.8%. Thus, after the GDYO nanosheets are coated with
iRGD peptide-modified red blood membrane (i-RBM) to achieve
tumor targeting, the biomimetic GDYO@i-RBM nanosheets can simultaneously enhance
tumor reoxygenation and blood perfusion for
PDT. This study provides new insights into utilizing novel water-splitting materials to relieve both diffusion- and perfusion-limited
hypoxia for the development of a novel therapeutic platform.